Document Detail


Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
MedLine Citation:
PMID:  17611870     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Amiodarone-induced thyrotoxicosis (AIT) may be caused by excessive thyroidal hormone synthesis and release (type 1) or by a destructive process (type 2). This differentiation is considered essential for therapeutic choice. PURPOSE: To evaluate the utility of color-flow Doppler sonography (CFDS) in the differential diagnosis and management of AIT. MATERIAL AND METHODS: The clinical and laboratory data, thyroid sonography (grayscale sonography [GSS], CFDS), thyroid radioiodine uptake (RAIU) and thyroid scintigraphy, treatment, and clinical outcome were retrospectively reviewed in 21 AIT patients. The CFDS pattern of thyroid nodules was separately described from that of the perinodular parenchyma, and AIT was classified as type 1 (increased blood flow) or type 2 (low/no blood flow). Type 1 AIT patients were treated with methimazole (alone or associated with potassium perchlorate), while type 2 patients were treated with prednisone or amiodarone withdrawal alone. RESULTS: Eleven patients with increased blood flow were considered as type 1, and 10 with low/no blood flow as type 2. Ten of the 11 patients in the first group showed a hypervascular nodular pattern, while one showed a hypervascular parenchymal pattern. Clinical diagnoses were toxic nodular goiter and Graves' disease, respectively. Of the 10 patients with low/no blood flow, six had normal thyroid volume, three small diffuse goiter, and one small multinodular goiter. The clinical outcome showed that 20 of the 21 patients were treatment responsive. CONCLUSION: CFDS is a useful tool in the differential diagnosis of AIT. This differentiation appeared to be of clinical relevance as regards therapeutic choice. Separate evaluation of parenchymal blood flow from that of nodules may prove beneficial in the diagnosis of underlying thyroid diseases in patients with type 1 AIT.
Authors:
M Loy; E Perra; A Melis; M E Cianchetti; M Piga; A Serra; G Pinna; S Mariotti
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  Acta radiologica (Stockholm, Sweden : 1987)     Volume:  48     ISSN:  0284-1851     ISO Abbreviation:  Acta Radiol     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-07-05     Completed Date:  2007-08-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706123     Medline TA:  Acta Radiol     Country:  Sweden    
Other Details:
Languages:  eng     Pagination:  628-34     Citation Subset:  IM    
Affiliation:
Ultrasonography Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy. mloy@pacs.unica.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Amiodarone / adverse effects*
Anti-Arrhythmia Agents / adverse effects*
Diagnosis, Differential
Female
Goiter, Nodular / complications,  diagnosis
Graves Disease / complications,  diagnosis
Humans
Male
Middle Aged
Retrospective Studies
Thyroid Function Tests / methods
Thyroid Gland / radionuclide imaging,  ultrasonography
Thyrotoxicosis / chemically induced*,  diagnosis*,  drug therapy
Thyrotropin / blood
Thyroxine / blood
Triiodothyronine / blood
Ultrasonography, Doppler, Color / methods*
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 1951-25-3/Amiodarone; 6893-02-3/Triiodothyronine; 7488-70-2/Thyroxine; 9002-71-5/Thyrotropin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of the optimal image reconstruction interval for coronary artery imaging using 64-slice c...
Next Document:  Massive postpartum hemorrhage treated with transcatheter arterial embolization: technical aspects an...